Compare GP & BFRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GP | BFRI |
|---|---|---|
| Founded | 2010 | 1997 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Construction/Ag Equipment/Trucks | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4M | 9.7M |
| IPO Year | 2020 | 2021 |
| Metric | GP | BFRI |
|---|---|---|
| Price | $1.05 | $0.79 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $2.75 |
| AVG Volume (30 Days) | ★ 207.8K | 121.4K |
| Earning Date | 11-11-2025 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $15,542,318.00 | ★ $37,164,000.00 |
| Revenue This Year | $81.12 | $9.70 |
| Revenue Next Year | $91.69 | $10.97 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 5.11 |
| 52 Week Low | $0.85 | $0.54 |
| 52 Week High | $10.90 | $1.87 |
| Indicator | GP | BFRI |
|---|---|---|
| Relative Strength Index (RSI) | 28.57 | 41.27 |
| Support Level | $0.92 | $0.80 |
| Resistance Level | $1.07 | $0.90 |
| Average True Range (ATR) | 0.12 | 0.06 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 32.02 | 51.15 |
GreenPower Motor Co Inc is the manufacturer and distributor of all-electric charter, school, and city buses. The company offers electric-powered transit buses deploying electric drive and battery technologies with a lightweight chassis and low-floor body. Its product line includes all-electric transit buses, all-electric school buses, and shuttle buses. The company's buses depend on clean sheet design and utilize a custom battery management system and a proprietary flex power system for the drive motors. Geographically, the company generates a majority of its revenue from the United States of America and the rest from Canada.
Biofrontera Inc is a United States-based biopharmaceutical company commercializing a portfolio of pharmaceutical products for the treatment of dermatological conditions with a focus on photodynamic therapy. The Company's licensed products, which include Ameluz as well as the BF-RhodoLED and RhodoLED XL lamps (together, the RhodoLED Lamps), are used for the treatment of actinic keratoses (AKs), which are pre-cancerous skin lesions.